Difference between revisions of "Team:Freiburg/Collaborations"

Line 54: Line 54:
 
</div>
 
</div>
 
<p>
 
<p>
Team <strong>Bielefeld</strong> sent us  a plasmid based on <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909</a> having a translation enhancing sequence (5’-UTR). We, the iGEM team <strong>Freiburg</strong> sent a plasmid containing turboYFP, a His- and a Halo-Tag. We aimed to compare if these parts will work in different cell-free protein synthesis environments.
+
Team <strong>Bielefeld</strong> sent us  a plasmid based on <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909</a> having a translation enhancing sequence (5’-UTR). We, the iGEM team <strong>Freiburg</strong>, sent a plasmid containing coding sequences for turboYFP, a His- and a Halo-Tag. We aimed to analyze if these parts will work in different cell-free protein synthesis environments.
 
</p>
 
</p>
 
</blockquote>
 
</blockquote>
  
 
<p>
 
<p>
To test the plasmid <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909</a>  containing a translation enhancing sequence (5'-UTR) we performed a cell.free expression our own mix and compared it to a sample containing no DNA (negative control). <br>
+
To test the plasmid <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909</a>  containing a translation enhancing sequence (5'-UTR) we performed a cell-free expression with our own mix and compared it to a sample containing no DNA (negative control). <br>
  
 
Both samples were treated alike and compared. All reactions were performed in duplicates.
 
Both samples were treated alike and compared. All reactions were performed in duplicates.
  
The samples were expressed for 4 hours at 37°C in a 384-well plate using our DiaMIX. After expression, the graph clearly indicates a successful expression of GFP. This underlines the ability of our mix to express vectors from various sources and the effectiveness of a 5'UTR.  
+
The samples were expressed for 4 hours at 37°C in a 384-well plate using our DiaMIX. After expression, the graph clearly indicates successful expression of GFP. This underlines the ability of the DiaMIX to express vectors from various sources and the effectiveness of a 5'UTR.  
 
</p>
 
</p>
  
Line 74: Line 74:
 
                 <div class="thumbcaption">
 
                 <div class="thumbcaption">
 
                     <p>
 
                     <p>
                         <strong>Figure 1: <strong>Expression of <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909.</a> </strong> </strong> The expression was conducted for 4 h and fluorescence measured every minute. Mean values and standard deviation was calculated from duplicates.
+
                         <strong>Figure 1: <strong>Expression of <a class="urlextern" href="http://parts.igem.org/Part:BBa_I746909" rel="nofollow" target="_Blank" title="http://parts.igem.org/Part:BBa_I746909">BBa_I746909.</a> </strong>. The expression was conducted for 4 h and relative fluorescence measured in one minute steps. Mean values and standard deviations were calculated from duplicates.
 
       </p>
 
       </p>
 
                 </div>
 
                 </div>
Line 91: Line 91:
 
<blockquote class="blockquote-plugin">
 
<blockquote class="blockquote-plugin">
 
<p>
 
<p>
<strong>Stockholm</strong> sent us the lysate of a HER2 domain binding affibody with a His-tag, as well as a glycerol stock of the Top10 bacteria strain they used for expression and organizes the sponsoring of the HER2-antigen from R&D-systems.  
+
<strong>Stockholm</strong> sent us the lysate of a HER2 domain binding affibody with a His-tag as well as a glycerol stock of the <i>E. coli</i> Top10 strain they used for expression and organized the sponsoring of the HER2-antigen from R&D-systems.  
 
<br/><strong>Freiburg</strong> tried to measure the binding of the purified HER2-antigen to the His-affibody lysate in iRIf.
 
<br/><strong>Freiburg</strong> tried to measure the binding of the purified HER2-antigen to the His-affibody lysate in iRIf.
 
</p>
 
</p>
Line 105: Line 105:
 
                 <div class="thumbcaption">
 
                 <div class="thumbcaption">
 
                     <p>
 
                     <p>
                         <strong>Figure 1: Amido black stained Western Blot of His-tagged affibody.</strong> No signal could be detected at 10 kDA (size of the affibody)
+
                         <strong>Figure 1: Amido black stained Western Blot of His-tagged affibody.</strong> No signal could be detected at 10 kDa (size of the affibody)
 
       </p>
 
       </p>
 
                 </div>
 
                 </div>
Line 113: Line 113:
  
 
<p>
 
<p>
As the iGEM Team Stockholm 2015 also works on a diagnostic tool, we thought it would be great to combine our two approaches. For the early detection of cancer biomarkers Stockholm tried to establish an affibody based bacterial biomarker assay (ABBBA). We planed to measure the binding of the purified HER2-antigen to the corresponding His-tagged affibody Stockholm sent us, which we immobilized on our Ni-NTA surface. Unfortunately we realized, that the HER2-antigen was also His-tagged, so it was impossible to measure the binding on a Ni-NTA surface. The HER2-antigen would bind to the surface, precluding a detection of its binding to the affibody.  
+
As the iGEM Team Stockholm 2015 also works on a diagnostic tool, we thought it would be great to combine our two approaches. For early detection of cancer biomarkers, Stockholm tried to establish an affibody based bacterial biomarker assay (ABBBA). We planed to measure the binding of the purified HER2-antigen to the corresponding His-tagged affibody Stockholm sent us, which we immobilized on our Ni-NTA surface. Unfortunately, we realized that the HER2-antigen was also His-tagged, so it was not suitable for an anlysis on a Ni-NTA surface. The HER2-antigen would bind to the surface, precluding a detection of its binding to the affibody.  
 
</p>
 
</p>
 
<p>
 
<p>
Line 119: Line 119:
 
</p>
 
</p>
 
<p>
 
<p>
A third possibility would have been to spot the His-affibody on a PDITC surface and flush over the antigen. Therefore it would have been necessary to purify the affibody, so we expressed it freshly from the glycerol stock Stockholm sent us. We performed a Western Blot of the pellet and the soluble fraction after the lysis of the <i>E.coli</i> cells that expressed the affibody. To identify the expressed protein we used Ni-NTA conjugated HRP antibody. Additionally we stained the membrane with amidoblack to determine a successful transfer of the proteins onto the membrane (fig.1). Unfortunately there was no signal with the chemiluminescence detection at the expected molecular weight. Therefore we did not perform the purification.
+
A third possibility would have been to spot the His-tagged affibody on a PDITC surface and flush the slide with the antigen. Therefore, it would have been necessary to purify the affibody, so we expressed it freshly from the glycerol stock Stockholm sent us. We performed a Western Blot of the pellet and the soluble fraction after lysis of the <i>E.coli</i> cells that expressed the affibody. To identify the expressed protein we used Ni-NTA conjugated HRP antibody. Additionally, we stained the membrane with amidoblack to determine successful transfer of the proteins onto the membrane (figure 1). Unfortunately, there was no signal detectable by chemiluminescence at the expected molecular weight. Therefore, we did not proceed with purification.
  
  
Line 144: Line 144:
  
 
<p>
 
<p>
The iGEM Team Amoy published regular Newsletters for the iGEM competition together with Paris_Bettencourt and Pasteur_Paris. It provided all iGEM Teams with the possibility to share their project idea, information about experiments they are performing or opinions about crucial topics of synthetic biology as well as to ask for help with complications they faced during this summer. All in all, there were seven issues published with different contents, three of them being special issues dealing with setting up an iGEM Team, the current situation of synthetic biology and software used in iGEM.
+
The iGEM Team Amoy published a regular Newsletters for the iGEM competition together with Paris_Bettencourt and Pasteur_Paris. They provided all iGEM Teams with the possibility to share their project idea, information about experiments they are performing or opinions about critical topics of synthetic biology as well as to ask for help with complications they faced during this summer. All in all, there were seven issues published with different contents, three of them being special issues dealing with setting up an iGEM Team, the current situation of synthetic biology and software used in iGEM.
 
</p>
 
</p>
 
<p>
 
<p>
Line 150: Line 150:
 
</p>
 
</p>
 
<p>
 
<p>
All the issues that were published during this year's iGEM competition and further information can be found <a class="urlextern" href="https://2015.igem.org/Team:Amoy/Newsletter#title" rel="nofollow" target="_Blank" title="https://2015.igem.org/Team:Amoy/Newsletter#title">here</a>.
+
All issues that were published during this year's iGEM competition and further information can be found <a class="urlextern" href="https://2015.igem.org/Team:Amoy/Newsletter#title" rel="nofollow" target="_Blank" title="https://2015.igem.org/Team:Amoy/Newsletter#title">here</a>.
 
</p>
 
</p>
 
</div>
 
</div>
Line 171: Line 171:
  
 
<p>
 
<p>
For the establishment of a <a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Results/Surface">specific surface</a> on the glass slide of the DiaCHIP we followed different approaches. Among others, we planned to test a surface with a SpyCatcher immobilized on top of an activated silane layer. The SpyCatcher would then interact specifically with cell-free expressed Spy-tagged proteins. In order to be able to verify the predicted function of our surface before performing <a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">cell-free expression</a>, the iGEM Team Tübingen kindly provided us with a purified carboxyfluorecine labelled <a href="http://parts.igem.org/Part:BBa_K1159201"target="_blank">SpyTag</a>.  
+
For the establishment of a <a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Results/Surface">specific surface</a> on the glass slide of the DiaCHIP we followed different approaches. Among others, we planned to test a surface with SpyCatcher immobilized on top of an activated silane layer. The SpyCatcher would then interact specifically with Spy-tagged proteins. In order to be able to verify the predicted function of our surface before performing <a class="wikilink1" href="https://2015.igem.org/Team:Freiburg/Results/Cellfree">cell-free expression</a>, the iGEM Team Tübingen kindly provided us with a purified carboxyfluorescine labeled <a href="http://parts.igem.org/Part:BBa_K1159201"target="_blank">SpyTag</a>.  
 
</p>
 
</p>
 
<p>
 
<p>
Unfortunately, due to time constraints, we were not able to establish a SpyCatcher surface and test the corresponding SpyTag we received from Team Tübingen.
+
Unfortunately, we were not able to establish a SpyCatcher surface and test the corresponding SpyTag we received from Team Tübingen due to time constraints.
 
</p>
 
</p>
 
</div>
 
</div>

Revision as of 02:13, 19 September 2015

""

Collaboration with iGEM Team Bielefeld

Team Bielefeld sent us a plasmid based on BBa_I746909 having a translation enhancing sequence (5’-UTR). We, the iGEM team Freiburg, sent a plasmid containing coding sequences for turboYFP, a His- and a Halo-Tag. We aimed to analyze if these parts will work in different cell-free protein synthesis environments.

To test the plasmid BBa_I746909 containing a translation enhancing sequence (5'-UTR) we performed a cell-free expression with our own mix and compared it to a sample containing no DNA (negative control).
Both samples were treated alike and compared. All reactions were performed in duplicates. The samples were expressed for 4 hours at 37°C in a 384-well plate using our DiaMIX. After expression, the graph clearly indicates successful expression of GFP. This underlines the ability of the DiaMIX to express vectors from various sources and the effectiveness of a 5'UTR.

Figure 1: Expression of BBa_I746909. . The expression was conducted for 4 h and relative fluorescence measured in one minute steps. Mean values and standard deviations were calculated from duplicates.

Collaboration with iGEM Team Stockholm

Stockholm sent us the lysate of a HER2 domain binding affibody with a His-tag as well as a glycerol stock of the E. coli Top10 strain they used for expression and organized the sponsoring of the HER2-antigen from R&D-systems.
Freiburg tried to measure the binding of the purified HER2-antigen to the His-affibody lysate in iRIf.

Figure 1: Amido black stained Western Blot of His-tagged affibody. No signal could be detected at 10 kDa (size of the affibody)

As the iGEM Team Stockholm 2015 also works on a diagnostic tool, we thought it would be great to combine our two approaches. For early detection of cancer biomarkers, Stockholm tried to establish an affibody based bacterial biomarker assay (ABBBA). We planed to measure the binding of the purified HER2-antigen to the corresponding His-tagged affibody Stockholm sent us, which we immobilized on our Ni-NTA surface. Unfortunately, we realized that the HER2-antigen was also His-tagged, so it was not suitable for an anlysis on a Ni-NTA surface. The HER2-antigen would bind to the surface, precluding a detection of its binding to the affibody.

To circumvent this problem we spotted the HER2-antigen on a PDITC surface and measured the binding of the affibody to the protein. Due to the small size of the affibody (under 10 kDa) it's not possible to observe the binding with iRIf because the detection limit of the system is around 10 kDa.

A third possibility would have been to spot the His-tagged affibody on a PDITC surface and flush the slide with the antigen. Therefore, it would have been necessary to purify the affibody, so we expressed it freshly from the glycerol stock Stockholm sent us. We performed a Western Blot of the pellet and the soluble fraction after lysis of the E.coli cells that expressed the affibody. To identify the expressed protein we used Ni-NTA conjugated HRP antibody. Additionally, we stained the membrane with amidoblack to determine successful transfer of the proteins onto the membrane (figure 1). Unfortunately, there was no signal detectable by chemiluminescence at the expected molecular weight. Therefore, we did not proceed with purification.

Collaboration with iGEM Team Amoy

We contributed to the iGEM Newsletter published by the iGEM Team Amoy.

The iGEM Team Amoy published a regular Newsletters for the iGEM competition together with Paris_Bettencourt and Pasteur_Paris. They provided all iGEM Teams with the possibility to share their project idea, information about experiments they are performing or opinions about critical topics of synthetic biology as well as to ask for help with complications they faced during this summer. All in all, there were seven issues published with different contents, three of them being special issues dealing with setting up an iGEM Team, the current situation of synthetic biology and software used in iGEM.

We were asked to contribute to the work of the iGEM Team and used this opportunity to share our project and thoughts with the iGEM community. We were delighted to be able to contribute to such a great piece of work.

All issues that were published during this year's iGEM competition and further information can be found here.

Collaboration with iGEM Team Tübingen

The iGEM Team Tübingen provided us with a construct coding for the Spy-Tag.

For the establishment of a specific surface on the glass slide of the DiaCHIP we followed different approaches. Among others, we planned to test a surface with SpyCatcher immobilized on top of an activated silane layer. The SpyCatcher would then interact specifically with Spy-tagged proteins. In order to be able to verify the predicted function of our surface before performing cell-free expression, the iGEM Team Tübingen kindly provided us with a purified carboxyfluorescine labeled SpyTag.

Unfortunately, we were not able to establish a SpyCatcher surface and test the corresponding SpyTag we received from Team Tübingen due to time constraints.